Explore 3 Stock Ideas & Industry Insights Download Free Report

XRF Scientific Ltd

Company price
2.08 AUD -0.03 ( 1.42%)
Last update at 2026-11-06T05:10:00Z
VOLUME
208962
Market Cap
300.84M
P/E
29.71

Momentum Score

…

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.06
Low
2.11
High
52 Week Price Range
1.56
Low
2.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

XRF Scientific Limited is an Australian-listed supplier of analytical instruments, consumables and laboratory services for elemental and materials testing across mining, environmental and industrial markets. Long-term growth could be supported by demand for on-site and lab analysis, recurring consumables and service revenue, and tightening environmental and resource-sector testing requirements, making it attractive for investors seeking exposure to a niche technical supplier.

Principal risks are cyclicality linked to mining and commodities, competition from larger instrument makers, manufacturing and supply-chain execution risk, and foreign-exchange sensitivity.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.11
Dividend Yield
2.13%
Revenue TTM
64.40M
Revenue Per Share
0.45
Gross Profit TTM
31.72M
Debt / Equity
0.04
ROE
16.57%
Net Debt
-7.12M
ROCE
24.20%
Diluted EPS TTM
0.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 15.37M 14.59M 13.46M 11.79M 8.19M
Minority interest - 0.05M -0.61M -0.50M -0.01M
Net income 10.49M 10.38M 8.89M 7.69M 6.08M
Selling general administrative - 11.84M 11.81M 10.14M 8.53M
Selling and marketing expenses - 1.09M 0.95M - -
Gross profit 30.10M 28.79M 26.27M 22.90M 17.32M
Reconciled depreciation - 1.69M 1.57M 1.20M 1.18M
Ebit 17.02M 14.82M 13.75M 12.01M 8.26M
Ebitda 18.72M 15.63M 15.32M 13.22M 9.44M
Depreciation and amortization 1.71M 0.81M 1.57M 1.20M 1.18M
Operating income 17.02M 15.77M 14.45M 11.97M 8.23M
Other operating expenses 47.11M 43.68M 45.46M 21.31M 13.63M
Interest expense 0.13M 0.26M 0.29M 0.22M 0.07M
Tax provision - 4.25M 3.97M 3.61M 2.10M
Interest income - 0.26M 0.28M 0.09M 0.00M
Net interest income - 0.01M -0.01M -0.14M -0.07M
Income tax expense 4.88M 4.25M 3.97M 3.61M 2.10M
Total revenue 64.13M 59.45M 59.84M 55.17M 40.01M
Total operating expenses 13.09M 13.02M 10.56M 12.22M 10.27M
Cost of revenue 34.02M 30.65M 33.57M 32.28M 22.69M
Total other income expense net -1.64M -1.18M -0.99M 0.04M 0.03M
Net income from continuing ops - 10.34M 9.50M 8.18M 6.09M
Net income applicable to common shares - 10.38M 8.89M 7.69M 6.08M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 78.65M 72.79M 68.23M 65.55M 55.56M
Intangible assets 3.80M 1.45M 1.20M 1.35M 1.49M
Other current assets 1.19M 0.05M 0.61M 0.11M 0.05M
Total liab 12.26M 12.62M 12.69M 15.97M 12.21M
Total stockholder equity 66.40M 60.17M 54.89M 49.25M 43.48M
Deferred long term liab - - - 0.86M 0.93M
Other current liab 6.02M 1.14M 5.68M 2.40M 0.89M
Common stock 28.16M - 21.41M 20.41M 19.63M
Capital stock - 24.96M 21.41M 20.41M 19.63M
Retained earnings 36.34M 32.23M 31.78M 26.65M 22.37M
Other liab - - - 1.42M 0.71M
Good will 20.12M 15.84M 15.42M 15.52M 15.46M
Other assets - - 0.00M 1.74M 1.96M
Cash 9.46M 12.23M 12.05M 10.40M 6.65M
Total current liabilities 8.34M 9.54M 10.45M 11.62M 9.66M
Current deferred revenue 0.36M - 1.29M 6.88M 6.03M
Net debt -7.12M - -8.67M -6.09M -3.14M
Short term debt 0.87M - 2.23M 1.39M 1.67M
Short long term debt - 0.17M 1.62M 0.78M 1.30M
Short long term debt total 2.34M - 3.38M 4.31M 3.51M
Other stockholder equity - - - -47.07M -42.00M
Property plant equipment - - - 10.41M 8.66M
Total current assets 41.40M 41.96M 39.20M 36.53M 28.91M
Net tangible assets - - - 33.25M 27.46M
Short term investments - - - 5.00M 0.00M
Net receivables 9.74M 10.02M 9.52M 8.63M 6.23M
Long term debt - 0.94M - 1.29M 1.46M
Inventory 21.02M 18.83M 17.02M 16.88M 15.52M
Accounts payable 1.10M 1.02M 1.25M 0.96M 1.07M
Accumulated other comprehensive income 1.90M - 1.70M 2.19M 1.48M
Non currrent assets other - - 1.20M -26.42M -24.68M
Non current assets total 37.25M 30.82M 29.03M 29.02M 26.64M
Capital lease obligations - 1.76M 1.76M 2.24M 0.75M
Long term debt total - - - 2.93M 1.84M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -2.21M -1.64M -0.78M -1.11M
Change to liabilities - - - 0.91M 1.16M
Total cashflows from investing activities -8.17M -2.21M - -0.78M -1.11M
Net borrowings - -0.50M - -1.20M 1.48M
Total cash from financing activities -5.99M -7.75M -4.80M -3.88M -0.65M
Change to operating activities - - - 0.58M -0.53M
Net income 10.49M 10.38M 8.89M 7.69M 6.08M
Change in cash -2.77M 0.18M 1.65M 3.75M 1.39M
Begin period cash flow 12.23M 12.05M 10.40M 6.65M 5.26M
End period cash flow 9.46M 12.23M 12.05M 10.40M 6.65M
Total cash from operating activities 11.39M 10.14M 8.09M 8.42M 3.15M
Depreciation 1.71M 1.69M 1.57M 1.20M 1.18M
Other cashflows from investing activities - 0.49M -0.03M -0.02M -0.14M
Dividends paid 5.02M -4.52M 3.60M 2.68M 2.13M
Change to inventory -2.19M -1.82M -0.14M -1.36M -3.01M
Change to account receivables 0.54M -0.75M -0.89M -2.40M -1.75M
Other cashflows from financing activities -0.80M -1.96M -0.75M -0.51M -0.47M
Change to netincome - - - 1.14M -0.13M
Capital expenditures 1.70M 1.75M 1.61M 0.78M 0.52M
Change in working capital -1.36M -2.00M -3.22M -1.61M -4.09M
Stock based compensation - 0.75M - 0.33M 0.06M
Other non cash items 0.55M -0.69M 11.31M 6.38M -0.19M
Free cash flow 9.69M 8.39M 6.45M 7.63M 2.63M

Peer Comparison*

Sector: Industrials Industry: Conglomerates

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
XRF
XRF Scientific Ltd
-0.03
1.42%
2.08 29.71 22.99 4.67 4.51 4.56 16.98
SGH
SGH Ltd
-0.02
0.05%
42.46 26.39 18.21 1.63 3.29 2.07 12.90
IFT
Infratil Ltd
-0.18
1.69%
10.49 44.46 35.34 3.06 1.66 6.78 17.02
NWH
NRW Holdings Ltd
-0.21
3.33%
6.09 19.09 14.18 0.68 4.23 0.74 6.89
AAL
Alfabs Australia Ltd
0.06
33.33%
0.24 20.00 - 0.54 0.93 0.94 5.75

Profile*

XRF Scientific Ltd

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.

86 Guthrie Street, Osborne Park, WA, Australia, 6017

61 8 9244 0600

Name Title Year Born
Mr. Vance Stazzonelli MD, Company Sec. & Director NA
Mr. Andrew Watson B.Comm, CA CFO & Joint Company Sec. NA
Mr. Stephen Prossor Bus. Devel. Mang. NA
Mr. Gino Manfredi Gen. Mang. of XRF Labware NA
Mr. Robert McConnell Gen. Mang. of XRF Technology WA NA
Mr. Jeffrey Brown Gen. Mang. of XRF Chemicals NA
Mr. Vance Stazzonelli MD, Company Secretary & Director NA
Mr. Andrew Watson B.Comm, CA CFO & Joint Company Secretary NA
Mr. Stephen Prossor Business Development Manager NA
Mr. Vance Stazzonelli MD, Company Secretary & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…